2019
DOI: 10.1371/journal.pone.0227009
|View full text |Cite
|
Sign up to set email alerts
|

Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India

Abstract: Methicillin-resistant Staphylococcus aureus (MRSA) infection is an important clinical concern in patients, and is often associated with significant disease burden and metastatic infections. There is an increasing evidence of heterogeneous vancomycin-intermediate S. aureus (hVISA) associated treatment failure. In this study, we aim to understand the molecular mechanism of teicoplanin resistant MRSA (TR-MRSA) and hVISA. A total of 482 MRSA isolates were investigated for these phenotypes. Of the tested isolates, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
23
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 30 publications
(24 citation statements)
references
References 71 publications
1
23
0
Order By: Relevance
“…Similarly, in the present study, all the hVISH isolates had dual mutations D471E with I527M in the rpo B gene. Interestingly, rpoB mutation-driven vancomycin heteroresistance has been reported in S. aureus [ 34 , 35 ], S. epidermidis [ 16 ] and S. capitis [ 7 ]. It is interesting to note that the occurrence of dual rpo B mutations (D471E and I527M) contributes to rifampicin resistance in S. haemolyticus .…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, in the present study, all the hVISH isolates had dual mutations D471E with I527M in the rpo B gene. Interestingly, rpoB mutation-driven vancomycin heteroresistance has been reported in S. aureus [ 34 , 35 ], S. epidermidis [ 16 ] and S. capitis [ 7 ]. It is interesting to note that the occurrence of dual rpo B mutations (D471E and I527M) contributes to rifampicin resistance in S. haemolyticus .…”
Section: Discussionmentioning
confidence: 99%
“…These heterogeneous populations represent a clinical challenge since they can lead to treatment failure. Sometimes, cross-resistance between teicoplanin and vancomycin can be observed [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…The glycopeptide family of antibiotics, to which teicoplanin also belongs, remains a mainstay option for suspected severe SSTI and invasive MRSA infections [3], even though there are multiple alternatives, and it has a potential for renal toxicity, Unfortunately, extensive antibiotic use in healthcare and agriculture in recent years [4] has determined a selection pressure on bacteria leading to a strong increase [5,6] in the emergence of MRSA isolates with reduced susceptibility to teicoplanin [7].…”
Section: Introductionmentioning
confidence: 99%